Evidence map›Paper›PMID 32005695›Full record

ArticleJournal of medical genetics2020

ATR-16 syndrome: mechanisms linking monosomy to phenotype.

Christian Babbs, Jill Brown, Sharon W Horsley, Joanne Slater, Evie Maifoshie, Shiwangini Kumar, Paul Ooijevaar, Marjolein Kriek, Amanda Dixon-McIver, Cornelis L Harteveld and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Christian BabbsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK christian.babbs@imm.ox.ac.uk veronica.buckle@imm.ox.ac.uk.ORCID 0000-0002-1898-5878
Jill BrownMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Sharon W HorsleyMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Joanne SlaterMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Evie MaifoshieMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Shiwangini KumarIGENZ Ltd, Auckland, New Zealand.
Paul OoijevaarDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Marjolein KriekDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Amanda Dixon-McIverIGENZ Ltd, Auckland, New Zealand.
Cornelis L HarteveldDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Jan Traeger-SynodinosDepartment of Medical Genetics, National and Kapodistrian University of Athens, Athens, Greece.
Andrew O M WilkieClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Douglas R HiggsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Veronica J BuckleMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK christian.babbs@imm.ox.ac.uk veronica.buckle@imm.ox.ac.uk.
University of Oxford · GBLeiden University Medical Center · NLJohn Radcliffe Hospital · GBNational and Kapodistrian University of Athens · GR

Funding

Medical Research Council G1000801Medical Research Council MC_U137961144Medical Research Council MC_U137961145Medical Research Council MC_UU_00016/1Medical Research Council MC_UU_00016/4Medical Research Council MC_UU_12009/1Medical Research Council MC_UU_12009/4
6 · The paper itself

Abstract

backgroundDeletions removing 100s-1000s kb of DNA, and variable numbers of poorly characterised genes, are often found in patients with a wide range of developmental abnormalities. In such cases, understanding the contribution of the deletion to an individual's clinical phenotype is challenging.

methodsHere, as an example of this common phenomenon, we analysed 41 patients with simple deletions of ~177 to ~2000 kb affecting one allele of the well-characterised, gene dense, distal region of chromosome 16 (16p13.3), referred to as ATR-16 syndrome. We characterised deletion extents and screened for genetic background effects, telomere position effect and compensatory upregulation of hemizygous genes.

resultsWe find the risk of developmental and neurological abnormalities arises from much smaller distal chromosome 16 deletions (~400 kb) than previously reported. Beyond this, the severity of ATR-16 syndrome increases with deletion size, but there is no evidence that critical regions determine the developmental abnormalities associated with this disorder. Surprisingly, we find no evidence of telomere position effect or compensatory upregulation of hemizygous genes; however, genetic background effects substantially modify phenotypic abnormalities.

conclusionsUsing ATR-16 as a general model of disorders caused by CNVs, we show the degree to which individuals with contiguous gene syndromes are affected is not simply related to the number of genes deleted but depends on their genetic background. We also show there is no critical region defining the degree of phenotypic abnormalities in ATR-16 syndrome and this has important implications for genetic counselling.

Indexed as

alpha-ThalassemiaAtaxia Telangiectasia Mutated ProteinsChromosome DeletionChromosomes, Human, Pair 16DNA Copy Number VariationsFemaleGene DeletionHumansIntellectual DisabilityMaleMonosomyPhenotypeAtaxia Telangiectasia Mutated ProteinsATR protein, humanATR16CNVdevelopmental delaythalassemia

Identifiers

PMID32005695
PMCPMC7279195
OpenAlexW2994631720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.